Biopharma Business

Business

Scottish universities link to develop stem cell therapies

Researchers at the Universities of Dundee and Edinburgh in Scotland are looking to work with the pharmaceutical industry to improve understanding of the biological processes that could form the basis

Read Full Article

Report highlights economic benefits of UK life sciences

The report, commissioned by the Association of the British Pharmaceutical Industry (ABPI) and supported by the Association of the British Healthcare Industry (ABHI), the BioIndustry Association (BIA), and the British

Read Full Article

EU and US Pledge to Recognize Each Other’s GMP Inspections

In a landmark decision, the United States FDA and the European Commission announced on March 2, 2017 that they will recognize each other’s inspection assessments at pharmaceutical manufacturing facilities. The Mutual

Read Full Article

MEPs criticise lack of transparency on R&D costs

Price rises in the EU stir Members of European Parliament to discuss ways to make medicines more affordable, including increasing clarity on R&D costs New medicine prices in the EU

Read Full Article

Sales surge for hospital software group Oneview

Oneview Healthcare, the Irish hospital software group, has reported strong revenue growth in its first year as a listed company. Sales have jumped to just over €9 million from €2.3

Read Full Article

Sales at Irish-headquartered Jazz Pharma rise 12%

Total revenues at Irish-headquartered Jazz Pharmaceuticals increased 12 per cent in 2016 to $1.5 billion (€1.42 billion ), while net income rose 14 per cent to $397 million. Net income

Read Full Article

Amarin reports 59% jump in sales for Vascepa drug

Amarin, the Irish biotech that has developed a drug to help reduce very high blood fat levels, saw sales jump 59 per cent last year. However, the company still reported

Read Full Article

DIA EuroMeeting explores the road ahead for drug development in the EU and UK

29 – 31 March 2017, Glasgow, United Kingdom. DIA, (founded as the Drug Information Association) announced critical workshops to be held at the 2017 DIA EuroMeeting. The goal of the

Read Full Article

Richmond Pharmacology opens new London research facility

Early-phase contract research organisation Richmond Pharmacology has opened its new research facility in London Bridge, at the site formerly known as the Guy’s Drug Research Unit. The organisation state that

Read Full Article

Perrigo sells Tysabri rights to Royalty Pharma in €2.7bn deal

Irish consumer healthcare and generic drug group Perrigo said has agreed to sell the royalty stream from its multiple sclerosis drug Tysabri to another Irish group, privately held Royalty Pharma,

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements